Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Theodore, W. H.
Right arrow Articles by Porter, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Theodore, W. H.
Right arrow Articles by Porter, R. J.
NEUROLOGY 1984;34:863
© 1984 American Academy of Neurology

Serial EEG in intractable epilepsy

William H. Theodore, Susumo Sato and Roger J. Porter

From the Clinical Epilepsy Section, Experimental Therapeutics Branch, IRP, NINCDS (Drs. Theodore and Porter), and the Epilepsy Branch, CDNDP, NINCDS (Drs. Theodore, Sato, and Porter).

We compared serial EEGs performed at admission, discharge, and follow-up (mean, 25 months) to clinical outcome in 70 patients with intractable epilepsy. The diagnosis in each case was confirmed by intensive monitoring. EEG features evaluated were background slowing, focal slowing, and focal, bilateral, or generalized epileptiform discharges. Clinical measures were seizure frequency and medication toxicity. No statistically significant correlations were found between improvement in any EEG feature and any clinical measure. EEG did not predict which patients would benefit from intensive monitoring. Serial EEGs may be of little value in assessing the results of treatment in patients with severe epilepsy.

Address correspondence and reprint requests to Dr. Theodore, Federal Building, Room 114, National Institutes of Health, Bethesda. MD 20205.

Presented in part at the 35th Annual Meeting of the American Academy of Neurology, San Diego, CA, April 1983.

Accepted for publication November 2, 1983.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1984 by AAN Enterprises, Inc.